New York State Common Retirement Fund’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Hold |
43,422
| – | – | ﹤0.01% | 2248 |
|
|
2025
Q1 | $238K | Buy |
43,422
+20,600
| +90% | +$113K | ﹤0.01% | 2158 |
|
|
2024
Q4 | $77K | Hold |
22,822
| – | – | ﹤0.01% | 2707 |
|
|
2024
Q3 | $65K | Hold |
22,822
| – | – | ﹤0.01% | 2781 |
|
|
2024
Q2 | $51K | Buy |
22,822
+38
| +0.2% | +$85 | ﹤0.01% | 3083 |
|
|
2024
Q1 | $50K | Sell |
22,784
-91
| -0.4% | -$200 | ﹤0.01% | 2984 |
|
|
2023
Q4 | $54K | Sell |
22,875
-260
| -1% | -$614 | ﹤0.01% | 2973 |
|
|
2023
Q3 | $43K | Buy |
23,135
+463
| +2% | +$861 | ﹤0.01% | 3066 |
|
|
2023
Q2 | $59K | Sell |
22,672
-115
| -0.5% | -$299 | ﹤0.01% | 3100 |
|
|
2023
Q1 | $37K | Sell |
22,787
-69,700
| -75% | -$113K | ﹤0.01% | 3055 |
|
|
2022
Q4 | $123K | Sell |
92,487
-13
| -0% | -$17 | ﹤0.01% | 2903 |
|
|
2022
Q3 | $144K | Buy |
92,500
+1,100
| +1% | +$1.71K | ﹤0.01% | 2894 |
|
|
2022
Q2 | $141K | Buy |
+91,400
| New | +$141K | ﹤0.01% | 2951 |
|
|
2021
Q3 | – | Sell |
-368
| Closed | -$1K | – | 3540 |
|
|
2021
Q2 | $1K | Sell |
368
-30,389
| -99% | -$82.6K | ﹤0.01% | 3487 |
|
|
2021
Q1 | $139K | Buy |
30,757
+10,800
| +54% | +$48.8K | ﹤0.01% | 2970 |
|
|
2020
Q4 | $98K | Buy |
19,957
+2,500
| +14% | +$12.3K | ﹤0.01% | 3034 |
|
|
2020
Q3 | $104K | Hold |
17,457
| – | – | ﹤0.01% | 2907 |
|
|
2020
Q2 | $46K | Hold |
17,457
| – | – | ﹤0.01% | 3161 |
|
|
2020
Q1 | $34K | Hold |
17,457
| – | – | ﹤0.01% | 3051 |
|
|
2019
Q4 | $123K | Sell |
17,457
-11,600
| -40% | -$81.7K | ﹤0.01% | 2943 |
|
|
2019
Q3 | $286K | Buy |
29,057
+8,400
| +41% | +$82.7K | ﹤0.01% | 2592 |
|
|
2019
Q2 | $236K | Buy |
20,657
+16,757
| +430% | +$191K | ﹤0.01% | 2737 |
|
|
2019
Q1 | $39K | Hold |
3,900
| – | – | ﹤0.01% | 3096 |
|
|
2018
Q4 | $66K | Buy |
+3,900
| New | +$66K | ﹤0.01% | 3057 |
|